Evidence map›Paper›PMID 41174699›Full record

ArticleBMC oral health2025

Re-appraisal of dental clearance protocol before anti-resorptive agents for osteoporosis using the modified Delphi technique.

Sarah Kho Xian Chua, Ruth Wei Choe, Catherine Hsu Ling Hong, Chee Weng Yong, Chien Joo Sim, Chong Meng Tay, Gabriel Keng Yan Lee, Jacinta Xiaotong Lu, Jing Li Lum, Joanne Ngo Uy and 4 more

Abstract read
In one paragraph

Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sarah Kho Xian Chua *National University Centre for Oral Health Singapore, Singapore, Singapore.
Ruth Wei Choe *National University Centre for Oral Health Singapore, Singapore, Singapore.
Catherine Hsu Ling HongFaculty of Dentistry, National University of Singapore, Singapore, Singapore.
Chee Weng YongNational University Centre for Oral Health Singapore, Singapore, Singapore. dencwy@nus.edu.sg.
Chien Joo SimNational University Centre for Oral Health Singapore, Singapore, Singapore.
Chong Meng TayNational University Centre for Oral Health Singapore, Singapore, Singapore.
Gabriel Keng Yan LeeFaculty of Dentistry, National University of Singapore, Singapore, Singapore.
Jacinta Xiaotong LuNational University Centre for Oral Health Singapore, Singapore, Singapore.
Jing Li LumNational University Centre for Oral Health Singapore, Singapore, Singapore.
Joanne Ngo UyNational University Centre for Oral Health Singapore, Singapore, Singapore.
Mei Na TanNational University Centre for Oral Health Singapore, Singapore, Singapore.
Ren Jie Jacob ChewFaculty of Dentistry, National University of Singapore, Singapore, Singapore.
Wataru OdeNational University Centre for Oral Health Singapore, Singapore, Singapore.
Wendy Chia-Wei WangNational University Centre for Oral Health Singapore, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients undergoing anti-resorptive agent (ARA) therapy are at risk of medication-related osteonecrosis of the jaw (MRONJ). Although existing guidelines encourage dental clearance prior to the initiation of ARA therapy, details on risk-appropriate treatment planning are insufficient.

methodsThis mixed-method study established a 13-person multidisciplinary expert panel to generate consensus statements through a modified Delphi process. Seven domains and 29 statements were identified through a comprehensive literature review and inputs from the expert panel. After two rounds of anonymous voting, 23 out of 29 statements achieved consensus. DISCUSSION: Domain 1 recommended the tailoring of treatment plans to the patients' medical history, dental history, social history, urgency of care, and life expectancy. Domain 2 recommended the removal of non-functional and misaligned teeth only if they are symptomatic. Domains 3 and 4 recommended that the management of caries and pulpal and periapical diseases in asymptomatic teeth does not have to precede the initiation of ARA therapy. Domain 5 recommended the removal of teeth with advanced periodontal disease but did not support the necessity of complete resolution of deep periodontal pockets prior to the initiation of ARA therapy. Domain 6 identified indications for the removal of dental implants prior to the initiation of ARA therapy and recommended the deferral of the management of most prosthesis-associated issues. Domain 7 which concerned the management of paediatric patients, failed to achieve consensus for any statements. This is congruent with the lack of evidence in the management of paediatric patients planned for ARA therapy.

conclusionThe consensus statements encourage clinicians to customise a risk-appropriate dental clearance protocol for each patient referred for dental clearance prior to ARA therapy for osteoporosis.

Indexed as

Bisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsOsteoporosisConsensusDelphi TechniqueHumansBone Density Conservation AgentsBisphosphonate-Associated osteonecrosis of the jawClinical protocolsDental careOsteonecrosisOsteoporosis

Identifiers

PMID41174699
PMCPMC12577338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.